Insider Trading History of Bronfeld Zeev

The following table details the insider trading activities (stock purchases, stock sales, and stock option exercises) by Bronfeld Zeev since 2007. The trader's CIK number is 1298522. At the time of the last reporting, Bronfeld Zeev was the 10% Owner of Protalix Biotherapeutics, Inc.. (stock ticker symbol PLX). Also see all insider trading activities at Protalix Biotherapeutics, Inc..

Note that in the past Bronfeld Zeev also reported insider trading activities as an insider of the following companies:

Yearly summary of insider trading at Global Energy Inc (GEYI) by Bronfeld Zeev

Insider Buying Insider Sales Option Exercises
Year Symbol Shares Value Shares Value Shares Value
2007 GEYI 30,000,000 $300,000 0 $0 0 $0

Yearly summary of insider trading at Oramed Pharmaceuticals Inc. (ORMP.OB) by Bronfeld Zeev

Insider Buying Insider Sales Option Exercises
Year Symbol Shares Value Shares Value Shares Value
2011 ORMP.OB 781,250 $250,000 350,000 $98,000 0 $0

Yearly summary of insider trading at Protalix Biotherapeutics, Inc. (PLX) by Bronfeld Zeev

Insider Buying Insider Sales Option Exercises
Year Symbol Shares Value Shares Value Shares Value
2014 PLX 0 $0 4,400,000 $10,868,000 0 $0


Insider trading activities at 3 companies by Bronfeld Zeev:

1. Global Energy Inc (GEYI)

2. Oramed Pharmaceuticals Inc. (ORMP.OB)

3. Protalix Biotherapeutics, Inc. (PLX)

Table 1. Insider trading of Global Energy Inc (GEYI) by Bronfeld Zeev

Trade Date Symbol Trade Type Shares Price ($) Value ($)
2007-04-30 GEYI Buy 30,000,000 .01 300,000

Table 2. Insider trading of Oramed Pharmaceuticals Inc. (ORMP.OB) by Bronfeld Zeev

Trade Date Symbol Trade Type Shares Price ($) Value ($)
2011-09-27 ORMP.OB Sale 350,000 .28 98,000
2011-03-31 ORMP.OB Buy 781,250 .32 250,000

Table 3. Insider trading of Protalix Biotherapeutics, Inc. (PLX) by Bronfeld Zeev

Trade Date Symbol Trade Type Shares Price ($) Value ($)
2014-08-13 PLX Sale 4,400,000 2.47 10,868,000

Insider trading activities including stock purchases, stock sales, and option exercises listed in the above table cannot be completely guaranteed as to their accuracy. For more information regarding the trades made by Bronfeld Zeev (10% Owner of Protalix Biotherapeutics, Inc. at the time of this reporting) see the Securities and Exchange Commission (SEC) website.



©2023, insider-monitor.com. All rights reserved.